|
|
|
|
|
|
|
|
|
|
Previous: PROTEIN DESIGN LABS INC/DE, 10-Q, EX-10.1, 2000-08-14 |
Next: METRETEK TECHNOLOGIES INC, 10QSB, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
THE ACCOMPANYING CONSOLIDATED FINANCIAL STATEMENTS AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> Jan-01-2000
<PERIOD-END> Jun-30-2000
<CASH> 194,973
<SECURITIES> 114,908
<RECEIVABLES> 2,272
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 312,153
<PP&E> 37,995
<DEPRECIATION> 0
<TOTAL-ASSETS> 354,658
<CURRENT-LIABILITIES> 9,461
<BONDS> 0
0
0
<COMMON> 199
<OTHER-SE> 185,471
<TOTAL-LIABILITY-AND-EQUITY> 354,658
<SALES> 28,343
<TOTAL-REVENUES> 35,864
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 30,073
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 3,460
<INCOME-PRETAX> 5,791
<INCOME-TAX> 0
<INCOME-CONTINUING> 5,791
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,791
<EPS-BASIC> 0.30
<EPS-DILUTED> 0.27
</TABLE>
|
|